By Chris Wack
Aclarion, a healthcare technology company, experienced a significant boost in its shares, increasing by 50% to reach $4.58. This surge follows the company's entrance into a strategic partnership agreement with Alphatec Spine, a wholly-owned subsidiary of Alphatec Holdings. The partnership solidifies a previously signed non-binding letter of intent between the two entities.
Despite this recent success, Aclarion's stock had hit its 52-week low of $2.75 on Friday and has seen a decline of 49% over the past year.
Through this collaboration, ATEC's AlphaInformatiX platform, which provides critical structural information, will be combined with Aclarion's Nociscan solution. Nociscan is equipped with biomarker data capable of identifying potentially painful discs. This integration will offer surgeons unprecedented access to comprehensive data on a single platform.
The ultimate goal is to improve clinical outcomes and reduce procedural costs for patients suffering from chronic low back pain.
This partnership encompasses multiple stages where Alphatec and Aclarion will join forces to identify key opinion leader surgeons who will evaluate the Nociscan technology. Beyond evaluation, both companies plan to co-market Nociscan in targeted markets. As part of their agreement, Aclarion will grant Alphatec exclusive distribution rights to include Nociscan as part of an integrated procedural solution. In return, Aclarion gains select access to Alphatec's esteemed surgeon network.
Elvis Whiskey’s Midnight Snack Whiskey
Our Latest News
New Jersey Lt. Gov. Sheila Oliver, Trailblazer, Dies at 71
New Jersey Lt. Gov. Sheila Oliver, the first Black woman to serve as speaker of the state assembly, passed away at 71. She leaves a legacy as a trailblazer and...
Swiss Watch Exports Show Normalization of Growth Trends
Swiss watch exports in 2023 show a normalization of growth trends, with strong performance in bimetallic watches and unexpected export growth to the U.S. catego...
Premier Foods Reports Strong Sales Growth in Third Quarter
Premier Foods reports a 14% increase in group sales and a notable spike of 13% in branded sales in Q3. Sweet-treat and international sales also soar.